Tredje AP fonden Decreases Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Tredje AP fonden decreased its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 50.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,663 shares of the medical technology company's stock after selling 3,662 shares during the period. Tredje AP fonden's holdings in Teleflex were worth $652,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of TFX. Janus Henderson Group PLC grew its holdings in shares of Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock valued at $1,329,704,000 after buying an additional 147,147 shares during the last quarter. State Street Corp boosted its stake in Teleflex by 1.0% during the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock valued at $508,757,000 after purchasing an additional 21,291 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Teleflex by 0.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company's stock worth $278,676,000 after purchasing an additional 5,746 shares in the last quarter. Cooke & Bieler LP raised its stake in shares of Teleflex by 22.1% in the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock worth $191,962,000 after purchasing an additional 195,150 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its holdings in shares of Teleflex by 0.4% during the third quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company's stock valued at $105,749,000 after purchasing an additional 1,884 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Teleflex Stock Performance

NYSE TFX traded down $1.01 on Wednesday, reaching $138.95. 1,172,792 shares of the stock were exchanged, compared to its average volume of 499,590. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.91. The firm has a market capitalization of $6.44 billion, a PE ratio of 27.62, a PEG ratio of 1.73 and a beta of 1.21. The company's 50-day simple moving average is $165.38 and its two-hundred day simple moving average is $195.90.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 0.98%. Teleflex's payout ratio is 95.77%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Bank of America lowered Teleflex from a "neutral" rating to an "underperform" rating and decreased their target price for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. Citizens Jmp cut shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Truist Financial cut their target price on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating for the company in a research report on Monday, March 3rd. Finally, StockNews.com lowered shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.